Nationwide surveillance system to evaluate hospital-acquired COVID-19 in Brazilian hospitals

Imagem de Miniatura
Arquivos
art_COSTA_Nationwide_surveillance_system_to_evaluate_hospitalacquired_COVID19_in_2022.PDF (265.44 KB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Autores
COSTA, M. Machado de Miranda
NOGUEIRA, M. D. S. P.
OLIVEIRA, L. S. C.
BARROS, L. de Souza
GONCALVES, M. R. S.
CARVALHO, A. A.
MOURA, H. L. C. Amaral de
Citação
JOURNAL OF HOSPITAL INFECTION, v.123, p.23-26, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Although the risk of SARS-CoV-2 transmission within hospitals has been well recognized, there is a paucity of data on its occurrence. Our aim was to report the incidence of hospital-acquired (HA) COVID-19 at Brazilian hospitals. Methods: We investigated the incidence of HA COVID-19 in Brazilian hospitals using data from a national surveillance system, from August 2020 through September 2021. Definitions of HA COVID-19 were: (1) symptom onset >14 days after hospital admission plus a positive SARS-CoV-2 RNA or antigen test; (2) symptom onset on days 8-14 after admission, plus a positive SARS-CoV-2 RNA or antigen test positive, plus documented high-risk exposure. We performed descriptive analyses and reported HA COVID-19 rates using pooled mean and percentile distribution. Results: A total of 48,634 cases of HA COVID-19 were reported from 1428 hospitals. Incidence ranged from 0.16/1000 patient-days at neonatal intensive care units (ICUs) to 5.8/1000 patient-days at adult ICUs. The highest incidence of HA COVID-19 was during the months March to July 2021, similar to that which was observed for community-acquired COVID-19. Conclusions: This report provides a national view of the burden of HA COVID-19. The highest incidence of HA COVID-19 similar that which was observed for community-acquired COVID-19. We believe that this reflects the difficulty of implementing preventive measures. Further studies evaluating risk factors for the hospital transmission of SARS-Cov-2 should clarify strategies to minimize the risk of HA COVID-19 and may be applicable to other respiratory diseases. Furthermore, the implementation of a national system to evaluate HA COVID-19 has the potential to shine a light on this problem and lead to interventions in each hospital.
Palavras-chave
COVID-19, Cluster, Nosocomial infection, Infection control
URI
https://observatorio.fm.usp.br/handle/OPI/48435
Referências
  1. [Anonymous], HTTPSCOVIDSAUDEGOVBR
  2. [Anonymous], 2020, GUIDANCE COVID 19 IN
  3. [Anonymous], 2020, GUIDELINES HLTHCARE
  4. [Anonymous], INTERIM GUIDANCE
  5. [Anonymous], 2020, UPDATE 2021 GUDELINE
  6. [Anonymous], INTERIM INFECT PREVE
  7. Barranco R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020489
  8. Read JM, 2021, LANCET, V398, P1037, DOI 10.1016/S0140-6736(21)01786-4
  9. Wang Dawei, 2020, JAMA, V323, P1061, DOI 10.1001/jama.2020.1585

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - ODS/03